BC
Bicara Therapeutics Inc. Common Stock
BCAX · NASDAQ
$22.67 -1.90% (-$0.44)
1M -6.98%
Market Cap $1.49B
P/E Ratio -
Div. Yield -
ROE 41.49%
Piotroski F-Score Weak
1/9Valuation
64 /100
Fair P/B 3.18x
P/FCF N/A
P/FFO N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 36.19%
ROIC 43.01%
Debt
100 /100
Low Current ratio 11.59x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
39 /100
Moderate EPS volatility 41.20%
Profitable years 0
Beta -0.82x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BCAX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Claire Mazumdar Clemon
Employees
103
Headquarters
Boston
Evenimente viitoare
09 NOV.
Earnings
Upcoming earnings report